For research use only
| Cat No. | ABC-X0255C |
| Product Type | Overexpression Stable Cell Lines |
| Cell Type | Epithelial |
| Species | Human |
| Host Cell | CHOK1 |
| Source Organ | Ovary |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Xpress™ Human CLDN5 over-expressing CHOK1 cells provide a robust system for studying tight junction dynamics and endothelial barrier regulation.
CLDN5 CHOK1 Overexpression Cell Line is developed by stable lentiviral integration of full-length human CLDN5 into CHOK1 cells. Expression is validated by qRT-PCR; cells are <P20. Target CLDN5 is a key component of tight junctions in endothelial cells, essential for vascular homeostasis. Dysregulation is implicated in stroke, multiple sclerosis, and brain tumors. AcceGen offers generation of stable overexpression cell lines targeting any gene of your interest. Polyclonal or monoclonal is optional based on customers' research needs.
| Species | Human |
| Cat.No | ABC-X0255C |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO2 |
| Source Organ | Ovary |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Overexpression Stable Cell Lines |
| Host Cell | CHOK1 |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
This model supports vascular biology studies, permeability assays, and therapeutic development for CNS disorders involving endothelial dysfunction.